Recruiting
Phase 2

Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT03784326

Conditions

Clinical Stage II Esophageal Adenocarcinoma AJCC v8

Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8

Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Atezolizumab

Conventional Surgery

Fluorouracil

Oxaliplatin

Tiragolumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information